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Case reports
A 20-year-old primigravida presented at a district hospital with 
a complaint of persistent headache and dizziness that did not 
respond to non-opioid analgesics. On examination, she was 14 weeks’ 
pregnant, apyrexial, with a pulse rate of 74 bpm and a blood pressure 
of 140/60 mmHg, and was HIV-negative. The patient was also 
irritable. Despite this, a thorough neurological and ophthalmological 
examination was not done, and non-opioid analgesics and anti-
emetics were prescribed, presumably because she was thought to have 
symptoms of early pregnancy. The patient’s headache and irritability 
persisted for the next 48 hours, when a lumbar puncture was done 
without seeking the opinion of a neurologist. 
The cerebrospinal fluid examination did not reveal any abnormality 
and the patient’s neurological condition deteriorated rapidly during 
the next 24 hours, without any further investigation. An autopsy 
revealed a cerebral tumour and cerebral oedema.
The second patient was also managed at a district hospital in a 
rural area. This patient (parity 1, gravida 2) booked for antenatal care 
at 12 weeks’ gestation. Two previous antenatal visits were uneventful. 
At 32 weeks’ gestational age she complained of severe headache and 
vomiting for a week.
The patient was admitted and treated for gastroenteritis and 
possibly hyperemesis gravidarum; an anti-emetic (metoclopramide 
(Maxolon)) was prescribed. During the next 3 weeks her headaches 
persisted and at 35 weeks she developed nystagmus, but without 
neurological signs. The patient was HIV-negative and liver function 
tests, including haemoglobin and platelets, were normal. A 
gynaecological consultation led to induction of labour and referral 
to a tertiary hospital for a head scan, which revealed metastatic 
tumours in the posterior cerebrum and a hydrocephalus. The latter 
was drained, but the patient died 2 days later without the site of the 
main tumour being identified. 
Discussion
These two patients illustrate that inexperienced doctors working in 
district hospitals in SA are not aware that severe persistent headache 
in pregnancy is a ‘red flag’ and warrants a neurological opinion. 
Most authors regard persistent severe headache as those continuing 
for >72 hours.[1,2] Moreover, the second case illustrates that severe 
headache occurring for the first time in the third trimester should 
have alerted the doctors to a secondary cause.[3] Severe headache 
in the third trimester, especially when associated with other signs 
such as vomiting and visual disturbances (e.g. scotomata, photopsia, 
diplopia, blurry vision) as in the second patient presented in this 
report, may be associated with pre-eclampsia.[4]
Headache is considered a promontory symptom for eclampsia, 
although it is only present in 56% of patients with eclampsia.[5] However, 
the incidence of headache is far greater in patients with pre-eclampsia; 
a case-control study showed an odds ratio of 4.95 (95% confidence 
interval 2.47 - 9.92) of headache being more frequent in pre-eclampsia.[6] 
No single type of headache, such as throbbing pain, generalised pressure, 
knife-like sensations or piercing, has been reported, but none of the 
above is typical of pre-eclampsia.[6] 
The patients presented did not have hypertension and/or 
proteinuria. Furthermore, the platelet counts and liver function 
tests were normal. Atypical presentations of headache, persistent 
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Headaches are common in pregnancy and the immediate postpartum period. Fortunately >90% of these headaches are primary and benign. 
Generally, the most common primary headache disorders have a peak incidence at a younger age and affect women disproportionately, 
especially in the reproductive phase of life. The higher incidence in females may reflect the relationship between headache and sex 
hormones, particularly oestrogen. In pregnancy, most headaches in the first trimester are primary, while the incidence of secondary 
headaches increases in the third trimester and the immediate postpartum period. This probably reflects when pre-eclampsia and changes 
in the coagulation system are the greatest. Despite this, 50 - 70% of headaches in late pregnancy have a primary benign cause. Common 
causes of headaches in pregnancy and the postpartum period are: migraine (vascular), tension headache (brain tumour), cluster headache 
(severe pre-eclampsia/eclampsia) and cough (postdural puncture, reversible cerebral vasoconstriction syndrome, idiopathic intracranial 
hypertension, cerebral venous thrombosis). This article presents two cases of maternal deaths arising from lack of awareness that acute 
severe headaches in pregnancy may have serious underlying pathology, and that persistent headache should be regarded as a ‘red flag’, as 
suggested by neurologists.
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symptomatology or focal neurological signs warrant consideration of 
other secondary causes of headache, such as tumours non-related to 
pre-eclampsia or intracranial pathology related to pre-eclampsia.[7,8] 
There is a reluctance to perform neuroimaging in pregnancy, even 
though it is often necessary. The major concern with radiological 
investigations is fetal safety. Magnetic resonance imaging as the 
preferred modality during pregnancy has been proven. Gadolinium 
is not used because it crosses the placental barrier.[9-11] However, in a 
neurological emergency, a computed axial tomography image is often 
the most appropriate modality to obtain timely information. The 
amount of radiation exposure from a non-contrast maternal head 
scan is only 200 mrad – a dose much less than that shown to cause 
fetal death or anomalies.[10,11] 
The two patients described above also illustrate the need to obtain 
a detailed history of the complaint of headache in pregnancy. New 
onset of headache in the third trimester of pregnancy or atypical 
headache at any stage of pregnancy, should alert a health professional 
to the likelihood of a secondary cause. Melhado et al.,[12] in a study 
of 1 029 pregnant women, found a subgroup of 76 women with new-
onset or a new type of headache in pregnancy, of whom 52.5% had 
a secondary headache. The most common causes were migraine 
(34.2%) and headache due to hypertension (32.9%).
Various retrospective and prospective studies have shown the 
frequency of migraine attacks to decrease by the end of the second 
trimester. However, because the headache and related symptoms of 
pre-eclampsia and migraine overlap, close follow-up with monitoring 
for signs of pre-eclampsia is necessary. It has also been shown that 
women with migraine are more likely to develop pre-eclampsia.[11]
In the second patient, metoclopramide was used as an anti-
emetic agent. This drug has generally been regarded as safe to use 
in pregnancy. However, clinicians should be aware that the use of 
this antidopaminergic agent can cause maternal extrapyramidal 
symptoms, such as acute dystonic reactions and dyskinesia, which 
may have occurred in this patient.[12] A careful medication history 
must be taken. This is of particular importance in SA owing to the 
high incidence of HIV infection in pregnancy and the potential 
side-effects, such as headache from antiretroviral agents and calcium 
channel antihypertensive agents, e.g. nifedipine.
In general, headaches in pregnancy are common – most are 
primary and benign. However, secondary causes of headache have 
dire consequences. The key messages warranting attention are 
shown below. Urgent neurological opinions are difficult to obtain in 
rural areas. Therefore, health authorities must consider setting up 
guidelines for neurological expert opinion.
Key messages
• Headaches in pregnancy are common, usually occur in the first 
trimester and are related to a primary headache disorder.
• During the last trimester and the postpartum period, there is an 
increased risk of secondary headaches. 
• Be aware of new-onset, atypical headaches and persistent headaches 
not responding to non-opioid analgesics.
• Be aware of headaches associated with hypertensive conditions of 
pregnancy and coagulopathies.
• Have a low threshold for imaging modalities of investigation.
• Obtain an expert opinion timeously.
Given the SA situation, it is important for educational institutions 
to include training on headaches in general and particularly in 
pregnancy. The National Department of Health should provide 
guidelines on the management of headaches in pregnancy. It is 
surprising that, as headaches are such a common disorder, there are 
no guidelines on its management. 
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